Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna…

Every morning, find a selection of analysts' recommendations covering North America. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Interactive Brokers Group, Inc.: Zacks downgrades to neutral from outperform and reduces the target price from USD 87 to USD 76.
• Microchip Technology, Inc.: Zacks downgrades to neutral from outperform and reduces the target price from USD 91 to USD 80.
• Spotify Technology S.a.: Arete Research upgrades to buy from neutral and reduces the target price from USD 680 to USD 586.
• The Mosaic Company: JP Morgan downgrades to underweight from neutral with a target price of USD 24.
• Edison International: Goldman Sachs maintains its neutral recommendation and raises the target price from USD 64 to USD 77.
• Elanco Animal Health Incorporated: BNP Paribas maintains its outperform recommendation and raises the target price from USD 24 to USD 29.
• Epam Systems, Inc.: Jefferies maintains its buy recommendation and reduces the target price from USD 275 to USD 193.
• Gartner, Inc.: Zacks maintains its neutral recommendation and reduces the target price from USD 246 to USD 156.
• Godaddy Inc.: Evercore ISI maintains its in-line recommendation and reduces the target price from USD 145 to USD 95.
• Medline Inc.: Citi maintains its buy recommendation and raises the target price from USD 48 to USD 60.
• Moderna, Inc.: Zacks maintains its neutral recommendation and raises the target price from USD 44 to USD 53.
• Salesforce, Inc.: Baird maintains its outperform recommendation and reduces the target price from USD 315 to USD 250.
• The Trade Desk, Inc.: BMO Capital Markets maintains its outperform rating and reduces the target price from USD 98 to USD 55.
• Viking Holdings Ltd: Wells Fargo maintains its equalweight recommendation and raises the target price from USD 62 to USD 77.